Lamotrigine
- Product NDC
- 68071-3514
- 11-digit product format
- 680713514
- Labeler code
- 68071
- Product ID
- 68071-3514_2d04df29-9c20-be48-e063-6294a90a16d1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamotrigine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA077633
- Marketing category
- ANDA
- Marketing start
- 2021-11-17
- Substance
- LAMOTRIGINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 68071-3514-6 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 68071-3514-6 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 68071-3514-6 | 0efc9e666f02… | f202fb6c5f17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077633-001 | LAMOTRIGINE | LAMOTRIGINE | 25MG | TABLET / ORAL | AB | 2009-01-27 | |
| A077633-002 | LAMOTRIGINE | LAMOTRIGINE | 50MG | TABLET / ORAL | 2009-01-27 | ||
| A077633-003 | LAMOTRIGINE | LAMOTRIGINE | 100MG | TABLET / ORAL | AB | 2009-01-27 | |
| A077633-004 | LAMOTRIGINE | LAMOTRIGINE | 150MG | TABLET / ORAL | AB | 2009-01-27 | |
| A077633-005 | LAMOTRIGINE | LAMOTRIGINE | 200MG | TABLET / ORAL | AB | 2009-01-27 | |
| A077633-006 | LAMOTRIGINE | LAMOTRIGINE | 250MG | TABLET / ORAL | 2009-01-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A077633-001 | AB |
| A077633-003 | AB |
| A077633-004 | AB |
| A077633-005 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A077633-001 | LAMOTRIGINE | 25MG | TABLET / ORAL | AB | 2009-01-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A077633-002 | LAMOTRIGINE | 50MG | TABLET / ORAL | 2009-01-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A077633-003 | LAMOTRIGINE | 100MG | TABLET / ORAL | AB | 2009-01-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A077633-004 | LAMOTRIGINE | 150MG | TABLET / ORAL | AB | 2009-01-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A077633-005 | LAMOTRIGINE | 200MG | TABLET / ORAL | AB | 2009-01-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A077633-006 | LAMOTRIGINE | 250MG | TABLET / ORAL | 2009-01-27 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077633-001 | LAMOTRIGINE | 25MG | TABLET / ORAL | AB | 2009-01-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A077633-002 | LAMOTRIGINE | 50MG | TABLET / ORAL | 2009-01-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077633-003 | LAMOTRIGINE | 100MG | TABLET / ORAL | AB | 2009-01-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A077633-004 | LAMOTRIGINE | 150MG | TABLET / ORAL | AB | 2009-01-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A077633-005 | LAMOTRIGINE | 200MG | TABLET / ORAL | AB | 2009-01-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A077633-006 | LAMOTRIGINE | 250MG | TABLET / ORAL | 2009-01-27 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A077633-001 | LAMOTRIGINE | 25MG | TABLET / ORAL | AB | 2009-01-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077633-002 | LAMOTRIGINE | 50MG | TABLET / ORAL | 2009-01-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A077633-003 | LAMOTRIGINE | 100MG | TABLET / ORAL | AB | 2009-01-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077633-004 | LAMOTRIGINE | 150MG | TABLET / ORAL | AB | 2009-01-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077633-005 | LAMOTRIGINE | 200MG | TABLET / ORAL | AB | 2009-01-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077633-006 | LAMOTRIGINE | 250MG | TABLET / ORAL | 2009-01-27 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077633-001 | LAMOTRIGINE | 25MG | TABLET / ORAL | AB | 2009-01-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077633-002 | LAMOTRIGINE | 50MG | TABLET / ORAL | 2009-01-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077633-003 | LAMOTRIGINE | 100MG | TABLET / ORAL | AB | 2009-01-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077633-004 | LAMOTRIGINE | 150MG | TABLET / ORAL | AB | 2009-01-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077633-005 | LAMOTRIGINE | 200MG | TABLET / ORAL | AB | 2009-01-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077633-006 | LAMOTRIGINE | 250MG | TABLET / ORAL | 2009-01-27 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A077633-001 | LAMOTRIGINE | 25MG | TABLET / ORAL | AB | 2009-01-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077633-002 | LAMOTRIGINE | 50MG | TABLET / ORAL | 2009-01-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A077633-003 | LAMOTRIGINE | 100MG | TABLET / ORAL | AB | 2009-01-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077633-004 | LAMOTRIGINE | 150MG | TABLET / ORAL | AB | 2009-01-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077633-005 | LAMOTRIGINE | 200MG | TABLET / ORAL | AB | 2009-01-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077633-006 | LAMOTRIGINE | 250MG | TABLET / ORAL | 2009-01-27 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077633-001 | LAMOTRIGINE | 25MG | TABLET / ORAL | AB | 2009-01-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077633-002 | LAMOTRIGINE | 50MG | TABLET / ORAL | 2009-01-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077633-003 | LAMOTRIGINE | 100MG | TABLET / ORAL | AB | 2009-01-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077633-004 | LAMOTRIGINE | 150MG | TABLET / ORAL | AB | 2009-01-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077633-005 | LAMOTRIGINE | 200MG | TABLET / ORAL | AB | 2009-01-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077633-006 | LAMOTRIGINE | 250MG | TABLET / ORAL | 2009-01-27 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077633-001 | LAMOTRIGINE | 25MG | TABLET / ORAL | AB | 2009-01-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077633-002 | LAMOTRIGINE | 50MG | TABLET / ORAL | 2009-01-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077633-003 | LAMOTRIGINE | 100MG | TABLET / ORAL | AB | 2009-01-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077633-004 | LAMOTRIGINE | 150MG | TABLET / ORAL | AB | 2009-01-27 | b8a1b40f171c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A077633-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A077633-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A077633-004 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A077633-005 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A077633-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A077633-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A077633-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A077633-005 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A077633-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A077633-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A077633-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A077633-005 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077633-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077633-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077633-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077633-005 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A077633-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A077633-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A077633-004 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A077633-005 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077633-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077633-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077633-004 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077633-005 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077633-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077633-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077633-004 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077633-005 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077633-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077633-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077633-004 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077633-005 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077633-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077633-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077633-004 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077633-005 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077633-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077633-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077633-004 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077633-005 | AB | 1 | 5bbf6a4d5a75… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lamotrigine
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LAMOTRIGINE | 100 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| U3H27498KS | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 198427 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 065e97c9-3c5f-16e6-e063-6294a90a13fc | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 14a9502b-3d70-0496-a7e1-b16edaa005b8 | Product name | 5 | 20250423 |
| 16d731ed-ff3e-e9a1-3e3e-1ef6b6be40a0 | Product name | 7 | 20250401 |
| e29d8e8b-4bc8-ebaf-f18e-e35287b19d6a | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-3514-6 | 2025-02-01 | C162847 | 48780-1 | 2cef2736-7753-d83d-e063-dadaa90ab31f | These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE tablets, for oral use Initial U.S. Approval: 1994 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3514-6 | Lamotrigine | 60 in 1 BOTTLE | TABLET | 60 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-3514 | LAMOTRIGINE TABLET [NUCARE PHARMACEUTICALS,INC.] | 2 | Current NDC, 1 package rows | 20250202_065e97c9-3c5f-16e6-e063-6294a90a13fc.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lamotrigine | LAMOTRIGINE | Cardinal Health 107, LLC | beb24a4f-ab0b-435a-b60b-2b8d565ecd75 | 2026-09-04 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | Cardinal Health 107, LLC | 20e156df-a2b6-4710-b526-0419cd17dd33 | 2026-09-04 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | American Health Packaging | 35aa48a2-2ce6-4a6e-bf5a-1bc6111d1234 | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | REMEDYREPACK INC. | 15d801a0-f0a5-40c1-bc88-d5ba9a02c696 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | Major Pharmaceuticals | 12e0be85-0961-4fe0-b973-83251ecf0f65 | 2026-05-04 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | American Health Packaging | 6034a8b8-9e80-43ca-b84f-ea82f788268c | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | Preferred Pharmaceuticals Inc. | 634dbe6c-4874-4d54-aa25-be02d3341f16 | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | Quallent Pharmaceuticals Health LLC | 7977c87f-b459-486a-9edc-0a2071c46f4c | 2026-01-03 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | Northwind Health Company, LLC | 03fd8413-df56-50ab-e063-6394a90a6950 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | Northstar Rx LLC. | aabc64fe-1f17-4140-81f2-7d4506db6c8b | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | Zydus Pharmaceuticals USA Inc. | e849033b-a3bc-408e-88de-7cd1d2660949 | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | Zydus Lifesciences Limited | 0f2f7421-56d4-45d0-9d2d-dc1edaede039 | 2025-10-04 | 077633 ANDA077633 | |
| Lamotrigine | LAMOTRIGINE | Bryant Ranch Prepack | 2cf33586-e48a-4b4e-b14b-33de2be63c1d | 2025-06-16 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | Bryant Ranch Prepack | 4bbc140c-6092-416d-865d-49b89c5ecdd0 | 2025-06-16 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | Bryant Ranch Prepack | cf03f130-067f-401c-8501-0d78a989a319 | 2025-06-16 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | NuCare Pharmaceuticals,Inc. | 065e97c9-3c5f-16e6-e063-6294a90a13fc | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 68071-3514 |
| Lamotrigine | LAMOTRIGINE | NCS HealthCare of KY, LLC dba Vangard Labs | e243e803-e95f-47a6-a6da-5fed657f4462 | 2024-08-06 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
| Lamotrigine | LAMOTRIGINE | A-S Medication Solutions | 5a9575bb-230e-46ae-b58e-41554bad45eb | 2023-11-24 | Boxed warning, Warnings, Adverse reactions | 077633 ANDA077633 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198427 | lamoTRIgine 100 MG Oral Tablet | PSN | 065e97c9-3c5f-16e6-e063-6294a90a13fc | 2 |
| 198427 | lamotrigine 100 MG Oral Tablet | SCD | 065e97c9-3c5f-16e6-e063-6294a90a13fc | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 68071-3514-6 | 68071351406 | 60 TABLET in 1 BOTTLE (68071-3514-6) | 60 tablet | 2023-09-27 | No | No | Current |